Line 7: |
Line 7: |
| |'''Significance (Recurrent, Diagnostic, Prognostic, Targeted treatment)''' | | |'''Significance (Recurrent, Diagnostic, Prognostic, Targeted treatment)''' |
| |'''Strength of Evidence (Level 1, 2, 3, see legend below table for criteria)''' | | |'''Strength of Evidence (Level 1, 2, 3, see legend below table for criteria)''' |
− | |'''References''' | + | |'''References''' |
| |- | | |- |
| | rowspan="9" |1 | | | rowspan="9" |1 |
Line 33: |
Line 33: |
| |1p13.2 | | |1p13.2 |
| |Loss | | |Loss |
− | |MAG13(kinase), BCL2 like and others | + | |''[[MAGI3]]'', BCL2 like and others |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
Line 120: |
Line 120: |
| |4q35.1 | | |4q35.1 |
| |Loss | | |Loss |
− | |''[[DCTD]], [[ING2]],'' and others | + | |''[[DCTD]], [[ING2]]'' and others |
| |Recurrent | | |Recurrent |
| |2 | | |2 |
Line 149: |
Line 149: |
| |5p14.3 | | |5p14.3 |
| |Gain | | |Gain |
− | |''CDH12,10'' | + | |''[[CDH10]], [[CDH12]]'' |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
Line 163: |
Line 163: |
| |5q13.2 | | |5q13.2 |
| |Loss | | |Loss |
− | |''[[OCLN]], [[NAIP]]'', and others | + | |''[[OCLN]], [[NAIP]]'' and others |
| |Recurrent | | |Recurrent |
| |2 | | |2 |
| |<ref name=":3" /> | | |<ref name=":3" /> |
| |- | | |- |
− | | rowspan="7" |6 | + | | rowspan="6" |6 |
| |6p | | |6p |
| |Gain | | |Gain |
Line 210: |
Line 210: |
| |3 | | |3 |
| |<ref name=":5" /> | | |<ref name=":5" /> |
− | |-
| |
− | |6q16.3
| |
− | |Loss
| |
− | |''[[COQR]], [[GRIK2]]''
| |
− | |Recurrent
| |
− | |3
| |
− | |<ref name=":1" />
| |
| |- | | |- |
| | rowspan="4" |7 | | | rowspan="4" |7 |
Line 235: |
Line 228: |
| |7p15.2 | | |7p15.2 |
| |Gain | | |Gain |
− | |''[[CBX3]], etc'' | + | |''[[CBX3]]'', etc |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
Line 267: |
Line 260: |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
− | |<ref name=":5" /> | + | |<ref name=":5" /> |
| |- | | |- |
| |8q | | |8q |
Line 285: |
Line 278: |
| |8q24.3 | | |8q24.3 |
| |Gain | | |Gain |
− | |''[[MAPK15]], [[TOP1MT]], [[CYP11B11]] (P450), ZNF41, 616, 707'' and ''ZNF517'' | + | |''[[MAPK15]], [[TOP1MT]], [[CYP11B11]] (P450), [[ZNF41]], [[ZNF517]], [[ZNF616]]'' and ''[[ZNF707]]'' |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
Line 365: |
Line 358: |
| |11q13.1/q13.4 | | |11q13.1/q13.4 |
| |Gain | | |Gain |
− | |''[[SCYL1]], [[MAP3K11]], [[CCND1]], [[FGF4]], [[FGF3]], [[NUMA]],'' and ''[[RELT]]'' | + | |''[[SCYL1]], [[MAP3K11]], [[CCND1]], [[FGF4]], [[FGF3]], [[NUMA]]'' and ''[[RELT]]'' |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
Line 576: |
Line 569: |
| |19p/ 19p13 | | |19p/ 19p13 |
| |Gain | | |Gain |
− | |''ICAM4,ICAM4, [[IBCL2L12]], [[TYK2]], [[IL2]],'' and ''[[DNMT1]]'' | + | |''ICAM4, ICAM4, [[IBCL2L12]], [[TYK2]], [[IL2]]'' and ''[[DNMT1]]'' |
| |Recurrent | | |Recurrent |
| |3 | | |3 |
Line 635: |
Line 628: |
| | rowspan="8" |X | | | rowspan="8" |X |
| |X | | |X |
− | |Gain/ Loss | + | |Gain / Loss |
| | | | | |
| |Recurrent | | |Recurrent |
Line 700: |
Line 693: |
| |Genome wide load of CNA > 100Mb | | |Genome wide load of CNA > 100Mb |
| | | | | |
− | |gain/loss | + | |Gain / Loss |
| | | | | |
| |associated with significant change in GEP at relapse | | |associated with significant change in GEP at relapse |